The mission of Emerging Microbes & Infections (EMI) is to provide a new integrated forum to allow for the timely dissemination of large amount of information gathered about microbes and infections, especially ones associated with increasing biological and clinical significance and pathogenic frequency.
As an Open Access journal, all articles in EMI are fully downloadable. Browse some of our most read articles selected from January to March 2021.
|Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates||Q. He, Q. Mao, C. An et al.|
|Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic||K. K.-W. Toabcd, S. Sridharabcd, K. H.-Y. Chiud et al.|
|Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants||S. Sua, Y. Shaob & S. Jianga|
|A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques||Y. Lia, Y. Bia, H. Xiaoa et al.|
|COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue||Y. Xi|
EMI will serve microbiologists, clinicians, public health workers, drug and vaccine developers, as well as policy makers by providing them with updated knowledge encompassing microbes and infections emerging in different countries and regions throughout the world. 2018 Impact Factor: 6.212